Prolacta Bioscience
Dedicated to improving the quality of life for the most fragile infants with 100% human milk-based nutrition.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD49—73m (Dealroom.co estimates May 2018.)
Industry California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $810k | Series A | |
$540k | Series B | ||
$12.0m | Series C | ||
$5.8m | Early VC | ||
$15.0m | Series D | ||
$35.0m | Late VC | ||
N/A | $8.9m | Early VC | |
Total Funding | CAD106m |
Related Content
Recent News about Prolacta Bioscience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.